基本信息
views: 276

Bio
I care for patients from the entire field of nuclear medicine, especially patients with thyroid diseases, but also Neuroendocrine Tumours (NET) and prostate cancer.
As the head of two of the largest nuclear medicine therapy wards in Europe, I was able to acquire extensive specialist knowledge, even with rare and complex diseases. Together with my team, I was able to introduce the new therapy with 177Lu-PSMA for patients with advanced prostate cancer in Vienna.
In addition, I head of the Congress Committee of the Austrian Society for Nuclear Medicine and Molecular Imaging, and was member of the "Nuclides in Nuclear Therapy" working group of the "Radiation Protection in Medicine" committee of the Radiation Protection Commission, Federal Office for Radiation Protection. As an author, I have published more than 140 scientific articles in international journals and so far have given over 100 specialist lectures at national and international congresses. I received several awards including the European Award in Medicine: Nuclear Medicine in 2022.
As the head of two of the largest nuclear medicine therapy wards in Europe, I was able to acquire extensive specialist knowledge, even with rare and complex diseases. Together with my team, I was able to introduce the new therapy with 177Lu-PSMA for patients with advanced prostate cancer in Vienna.
In addition, I head of the Congress Committee of the Austrian Society for Nuclear Medicine and Molecular Imaging, and was member of the "Nuclides in Nuclear Therapy" working group of the "Radiation Protection in Medicine" committee of the Radiation Protection Commission, Federal Office for Radiation Protection. As an author, I have published more than 140 scientific articles in international journals and so far have given over 100 specialist lectures at national and international congresses. I received several awards including the European Award in Medicine: Nuclear Medicine in 2022.
Research Interests
Papers共 392 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Kilian Kluge, Vincent Lotz,Holger Einspieler,David Haberl,Clemens Spielvogel, Dominik Amereller,Gero Kramer,Bernhard Grubmüller,Shahrokh Shariat,Alexander Haug,Marcus Hacker,Lukas Kenner,Gerda Egger
Clinical Epigeneticsno. 1 (2025): 1-11
David Haberl,Jing Ning,Kilian Kluge, Katarina Kumpf,Josef Yu, Zewen Jiang,Claudia Constantino, Alice Monaci, Maria Starace,Alexander R. Haug,Raffaella Calabretta,Luca Camoni,Francesco Bertagna,Katharina Mascherbauer,Felix Hofer,Domenico Albano,Roberto Sciagra,Francisco Oliveira,Durval Costa,Christian Nitsche,Marcus Hacker,Clemens P. Spielvogel
European Journal of Nuclear Medicine and Molecular Imagingpp.1-14, (2025)
Kilian Kluge,David Haberl,Alexander Haug,Lukas Kenner,Gero Kramer, Shahrokh Shariat, Katarina Kumpf,Marcus Hacker
European journal of nuclear medicine and molecular imaging (2025)
Jing Ning,Clemens P. Spielvogel,David Haberl,Karolina Trachtova,Stefan Stoiber,Sazan Rasul,Vojtech Bystry,Gabriel Wasinger,Pascal Baltzer,Elisabeth Gurnhofer,Gerald Timelthaler,Michaela Schlederer,Laszlo Papp,Helga Schachner,Thomas Helbich,Markus Hartenbach,Bernhard Grubmueller,Shahrokh F. Shariat,Marcus Hacker,Alexander Haug,Lukas Kenner
THERANOSTICSno. 12 (2024): 4570-4581
Daria Kifjak,Maximilian Hochmair,Daniel Sobotka,Alexander R. Haug,Raphael Ambros,Florian Prayer,Benedikt H. Heidinger,Sebastian Roehrich,Ruxandra-Iulia Milos,Wolfgang Wadsak,Thorsten Fuereder,Dagmar Krenbek,Andreas Fazekas,Michael Meilinger,Marius E. Mayerhoefer,Georg Langs,Christian Herold,Helmut Prosch,Lucian Beer
Nuklearmedizin - NuclearMedicineno. 02 (2024): 57-61
Insights into Imagingno. 1 (2024): 1-12
Load More
Author Statistics
#Papers: 392
#Citation: 7544
H-Index: 47
G-Index: 74
Sociability: 7
Diversity: 3
Activity: 51
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn